Skip to main content
OpenTrials
Completed

NCT Number: NCT06072755

Tissue Oxygen Use With Combined Arteriovenous Noninvasive Oximetry

The goal of this observational study is to find out if researchers can measure oxygen consumption in the body without having to draw blood from lines in arteries and central veins.

Participants will undergo measurements of arterial blood oxygen saturation using both finger and neck pulse oximeters.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University of Wisconsin

Madison, Wisconsin, 53705, United States

About this study

TOUCAN-1 is a study to estimate the accuracy and precision of pulse oximetry as a noninvasive tool for oxygen consumption measurement. Researchers will use a pair of commercially-available, noninvasive pulse oximeters to estimate the oxygen saturation of blood in the internal jugular vein, and compare it to the directly measured oxygen saturation in sampled jugular blood. Researchers will then measure the arterial oxygen saturation in a finger, and compare it to the directly measured oxygen saturation in sampled radial arterial blood.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Inpatient at the University of Wisconsin University Hospital
  • Has an internal jugular venous central line
  • Has a radial arterial line

Exclusion criteria

  • Currently receiving extracorporeal membrane oxygenation (ECMO)
  • Currently receiving continuous renal replacement therapy (CRRT/CVVH)
  • All usable lumens of the participant's jugular catheter are in use, and interruption of any medical or therapy through any lumen would, in the view of the primary care team, compromise the participant's care.
  • Jugular venous catheter is not functional or position is not confirmed by radiography
  • Arterial cannula is not functional
  • Known history of sickle cell anemia or other hemoglobinopathy
  • Therapy with any of the following medications:
  • Nitroprusside
  • Hydroxocobalamin
  • Indocyanine green
  • Norepinephrine
  • Vasopressin
  • Epinephrine
  • Any other medication or therapy that, in the judgement of the study investigators, may affect the accuracy and precision of the noninvasive oximetry results

Treatment and study plan

Finger pulse oximetry probe

Device

This finger probe will be used to make noninvasive measurements of systemic arterial and central venous oxygen saturations.

Transreflectance oximetry probe

Device

This neck probe will be used to make noninvasive measurements of systemic arterial and central venous oxygen saturations.

Primary outcomes

  1. Accuracy of digital pulse oximetry

    Time frame: Through study completion, approximately 20 minutes

    Difference in the standard deviation of the arteriovenous saturation difference comparing noninvasive photoplethysmography to invasive blood sampling and oximetry

  2. Accuracy of jugular pulse oximetry

    Time frame: Through study completion, approximately 20 minutes

    Difference in the standard deviation of the arteriovenous saturation difference comparing noninvasive photoplethysmography to invasive blood sampling and oximetry

Sponsors and collaborators

Lead sponsor

University of Wisconsin, Madison

Other

Collaborators

  • AABB Foundation

Registry information

Official study title

Bedside Tissue Oxygenation Monitoring With Noninvasive Jugular Venous Oximetry

Acronym: TOUCAN-1

Important dates

Study start
2024
Primary completion
2024
Study completion
2024
First posted
Oct 10, 2023
Registry last updated
Aug 23, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.